[{"address1": "3805 Old Easton Road", "city": "Doylestown", "state": "PA", "zip": "18902", "country": "United States", "phone": "617 463 9385", "website": "https://www.aprea.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidate is the ATRN-119 that is in Phase I clinical trials for treating advanced solid tumors, ovarian, breast, and prostate cancers. The company is also developing ATRN-1051, ATRN-354, and APRE-DDRi for the treatment of advanced solid tumors. The company is headquartered in Doylestown, Pennsylvania.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Dansu  Li Ph.D.", "title": "Head of Technology", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lars B. Abrahmsen Ph.D.", "age": 66, "title": "Senior VP & Chief Scientific Officer", "yearBorn": 1957, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michel  Afargan Ph.D.", "title": "Head of Pharmacology Development", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ze'ev  Weiss B.Sc., C.P.A.", "age": 61, "title": "Chief Business Advisor", "yearBorn": 1962, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Andrea  Epstein", "title": "Controller", "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 2, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1709251200, "maxAge": 86400, "priceHint": 2, "previousClose": 6.07, "open": 5.92, "dayLow": 5.91, "dayHigh": 6.8, "regularMarketPreviousClose": 6.07, "regularMarketOpen": 5.92, "regularMarketDayLow": 5.91, "regularMarketDayHigh": 6.8, "trailingPE": 0.5434606, "forwardPE": -4.2884617, "volume": 28419, "regularMarketVolume": 28419, "averageVolume": 36195, "averageVolume10days": 20480, "averageDailyVolume10Day": 20480, "bid": 6.4, "ask": 6.3, "bidSize": 800, "askSize": 900, "marketCap": 24998322, "fiftyTwoWeekLow": 2.78, "fiftyTwoWeekHigh": 8.847, "priceToSalesTrailing12Months": 42.861786, "fiftyDayAverage": 6.38078, "twoHundredDayAverage": 4.540725, "currency": "USD", "enterpriseValue": 12665648, "floatShares": 3611473, "sharesOutstanding": 3736670, "sharesShort": 117112, "sharesShortPriorMonth": 79377, "sharesShortPreviousMonthDate": 1707955200, "dateShortInterest": 1710460800, "sharesPercentSharesOut": 0.0313, "heldPercentInsiders": 0.114879996, "heldPercentInstitutions": 0.17636, "shortRatio": 1.66, "shortPercentOfFloat": 0.0372, "impliedSharesOutstanding": 3736670, "bookValue": 4.537, "priceToBook": 1.4745426, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -14286756, "trailingEps": 12.31, "forwardEps": -1.56, "lastSplitFactor": "1:20", "lastSplitDate": 1676246400, "enterpriseToRevenue": 21.716, "enterpriseToEbitda": -0.819, "52WeekChange": 0.5067568, "SandP52WeekChange": 0.27864528, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "APRE", "underlyingSymbol": "APRE", "shortName": "Aprea Therapeutics, Inc.", "longName": "Aprea Therapeutics, Inc.", "firstTradeDateEpochUtc": 1570109400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "9a8f76c4-98d0-37f2-b77b-05a35baa6936", "messageBoardId": "finmb_329831339", "gmtOffSetMilliseconds": -14400000, "currentPrice": 6.69, "targetHighPrice": 20.0, "targetLowPrice": 11.0, "targetMeanPrice": 15.67, "targetMedianPrice": 16.0, "recommendationMean": 1.7, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 21606820, "totalCashPerShare": 3.979, "ebitda": -15464911, "quickRatio": 4.927, "currentRatio": 5.135, "totalRevenue": 583231, "revenuePerShare": 0.161, "returnOnAssets": -0.36625, "returnOnEquity": -0.63189, "freeCashflow": -7674456, "operatingCashflow": -12177608, "operatingMargins": -261.0962, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-03-29"}]